Skip to main content
SpringerLink
Log in

Global Health and Viral Diseases: Past, Present, and Future

  • Chapter
  • First Online:
Viral Drug Delivery Systems

  • 265 Accesses

Abstract

Viral diseases are one of the most common and rapidly contagious ways to impair one’s health. Hence, finding new ways to combat the spread and treat the viruses can be beneficial to global health overall. Some of these common and dangerous viral diseases include influenza, HIV/AIDS, HPV, and measles, mumps, and rubella (MMR). Prior to modern medicine, thousands faced death at the hand of these diseases; however, today, we can develop interventions and technology that could save most from their devastating effects. Although most of these diseases are highly preventable either via vaccines or preemptive safe practices, their access globally is highly limited by a nation’s finances, resources, and initiatives. In order to accomplish the task of eliminating and reducing the spread of viral diseases, the HPV and MMR vaccines must be widely distributed to target populations, perhaps even made a requirement for school admission. Supplementary immunization activities (SAIs) are also recommended to maintain and enforce immunization strategies. For viruses that result in sexually transmitted diseases (STIs), educational resources as well as screening opportunities are needed to aid in the accurate recording of transmission and to execute preventative measures. Viral diseases prove fatal for many all around the world. By initiating plans for intervention and treatment of viral diseases that affect those around the world, we can significantly improve global health access and quality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Geldborn HR. Structure and classification of viruses. In: Medical microbiology. 4th ed. The University of Texas Medical Branch at Galveston; 1996. Chapter 41.

    Google Scholar 

  2. Crespo-Barreda A, Encabo-Berzosa MM, González-Pastor R, Ortíz-Teba P, Iglesias M, Serrano JL, Martín-Duque P. Viral and nonviral vectors for in vivo and ex vivo gene therapies. In: Laurence J, Baptista P, Atala A, Beusekom MV, editors. Translating regenerative medicine to the clinic. Zaragoza: Elsevier; 2016. p. 155–77.

    Chapter  Google Scholar 

  3. Kobayashi K, Hisamatsu K, Suzui N, Hara A, Tomita H, Miyazaki T. A review of HPV-related head and neck cancer. J Clin Med. 2018;7(9):241. https://doi.org/10.3390/jcm7090241.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bankamp B, Hickman C, Icenogle JP, Rota PA. Successes and challenges for preventing measles, mumps and rubella by vaccination. In: Current opinion in virology, vol. 34. Atlanta: Elsevier; 2019. p. 110–6.

    Google Scholar 

  5. Su S-B, Chang H-L, Chen K-T. Current status of mumps virus infection: epidemiology, pathogenesis, and vaccine. Int J Environ Res Public Health. 2020;17(5):1686. https://doi.org/10.3390/ijerph17051686.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Shimizu K. History of influenza epidemics and discovery of influenza virus. Nihon Rinsho. 1997;55(10):2505–11.

    CAS  PubMed  Google Scholar 

  7. Van Epps HL. Influenza: exposing the true killer. J Exp Med. 2006;203(4):803. https://doi.org/10.1084/jem.2034fta.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Abrahão JS, de Arruda LB. Special issue “Emerging viruses: surveillance, prevention, evolution, and control”. Viruses. 2020;12(3):306. https://doi.org/10.3390/v12030306. Published 11 Mar 2020.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol. 2008;3:499–522. https://doi.org/10.1146/annurev.pathmechdis.3.121806.154316.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. 2020–2021 flu season summary. Centers for Disease Control and Prevention. https://www.cdc.gov/flu/season/faq-flu-season-2020-2021.htm. Published 25 Oct 2021.

  11. Mousa HA. Prevention and treatment of influenza, influenza-like illness, and common cold by herbal, complementary, and natural therapies. J Evid Based Complementary Altern Med. 2017;22(1):166–74. https://doi.org/10.1177/2156587216641831.

    Article  CAS  PubMed  Google Scholar 

  12. Nabeshima S, Kashiwagi K, Ajisaka K, et al. A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza. J Infect Chemother. 2012;18(4):534–43. https://doi.org/10.1007/s10156-012-0378-7.

    Article  CAS  PubMed  Google Scholar 

  13. Gupta YK, Meenu M, Mohan P. The Tamiflu fiasco and lessons learnt. Indian J Pharmacol. 2015;47(1):11–6. https://doi.org/10.4103/0253-7613.150308.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Heneghan CJ, Onakpoya I, Thompson M, Spencer EA, Jones M, Jefferson T. Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014;348:g2547. https://doi.org/10.1136/bmj.g2547. Published 9 Apr 2014.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Recommended composition of influenza virus vaccines for use in the 2022–2023 Northern Hemisphere influenza season. World Health Organization. https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2022-2023-northern-hemisphere-influenza-season. Published 25 Feb 2022.

  16. Acute HIV infection: NIH. HIV.gov. https://clinicalinfo.hiv.gov/en/glossary/acute-hiv-infection.

  17. Acquired immunodeficiency syndrome (AIDS): NIH. HIV.gov. https://clinicalinfo.hiv.gov/en/glossary/acquired-immunodeficiency-syndrome-aids.

  18. HIV/AIDS. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/hiv-aids. Published 30 Nov 2021.

  19. About HIV/AIDS. Centers for Disease Control and Prevention. https://www.cdc.gov/hiv/basics/whatishiv.html. Published 1 June 2021.

  20. HIV.gov. How do you get or transmit HIV? n.d. Retrieved on 17 May 2021, from https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/how-is-hiv-transmitted.

  21. Centers for Disease Control and Prevention. HIV and youth. 2013. Retrieved 17 May 2021, from http://www.cdc.gov/hiv/risk/age/youth/index.html.

  22. The global HIV/AIDS epidemic. HIV.gov. https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics. Published 30 Nov 2021.

  23. Global HIV & AIDS statistics – fact sheet. UNAIDS. https://www.unaids.org/en/resources/fact-sheet.

  24. Tanser F, de Oliveira T, Maheu-Giroux M, Bärnighausen T. Concentrated HIV subepidemics in generalized epidemic settings. Curr Opin HIV AIDS. 2014;9(2):115–25. https://doi.org/10.1097/COH.0000000000000034.

    Article  PubMed  PubMed Central  Google Scholar 

  25. HIV prevalence and incidence, 1980–2010. Centers for Disease Control and Prevention. https://www.cdc.gov/nchhstp/newsroom/2012/hivincidencegraphics.html.

  26. Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) results. Seattle: Institute for Health Metrics and Evaluation (IHME); 2021.

    Google Scholar 

  27. Covid-19 vaccines. World Health Organization. https://www.afro.who.int/health-topics/coronavirus-covid-19/vaccines.

  28. Kemnic TR, Gulick PG. HIV antiretroviral therapy. [Updated 2022 Apr 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

    Google Scholar 

  29. The HIV life cycle. National Institutes of Health. https://hivinfo.nih.gov/understanding-hiv/fact-sheets/hiv-life-cycle. Published 4 Aug 2021.

  30. Antiretroviral Therapy (ART): NIH. HIV.gov. https://clinicalinfo.hiv.gov/en/glossary/antiretroviral-therapy-art.

  31. About PrEP. Centers for Disease Control and Prevention. https://www.cdc.gov/hiv/basics/prep/about-prep.html. Published 20 Apr 2022.

  32. Mermin J. Prep: a powerful prevention tool. HIV.gov. https://www.hiv.gov/blog/prep-a-powerful-prevention-tool. Published 8 Apr 2021.

  33. NIH launches clinical trial of three mRNA HIV vaccines. National Institutes of Health. https://www.nih.gov/news-events/news-releases/nih-launches-clinical-trial-three-mrna-hiv-vaccines. Published 14 Mar 2022.

  34. Cheng L, Wang Y, Du J. Human papillomavirus vaccines: an updated review. Vaccines (Basel). 2020;8(3):391. https://doi.org/10.3390/vaccines8030391. Published 16 July 2020.

    Article  CAS  PubMed  Google Scholar 

  35. Juckett G, Hartman-Adams H. Human papillomavirus: clinical manifestations and prevention. Am Fam Physician. 2010;82(10):1209–13.

    PubMed  Google Scholar 

  36. IARC Working Group on the evaluation of carcinogenic risks to humans. Human papillomaviruses. Lyon (FR): International Agency for Research on Cancer; 2007. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 90.) 1, Human Papillomavirus (HPV) Infection.

    Google Scholar 

  37. Luria L, Cardoza-Favarato G. Human papillomavirus. [Updated 2022 Jan 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

    Google Scholar 

  38. Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(Suppl 5):F12–23. https://doi.org/10.1016/j.vaccine.2012.07.055.

    Article  PubMed  Google Scholar 

  39. Kombe Kombe AJ, Li B, Zahid A, et al. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front Public Health. 2021;8:552028. https://doi.org/10.3389/fpubh.2020.552028. Published 20 Jan 2021.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Braaten KP, Laufer MR. Human papillomavirus (HPV), HPV-related disease, and the HPV vaccine. Rev Obstet Gynecol. 2008;1(1):2–10.

    PubMed  PubMed Central  Google Scholar 

  41. Guerra FM, et al. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis. 2017;17(12):e420–8.

    Article  PubMed  Google Scholar 

  42. Bellini WJ, Rota JS, Rota PA. Virology of measles virus. J Infect Dis. 1994;170(Suppl. 1):S15–23.

    Article  PubMed  Google Scholar 

  43. Rubin S, et al. Molecular biology, pathogenesis and pathology of mumps virus. J Pathol. 2015;235(2):242–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Frey TK. Molecular biology of rubella virus. Adv Virus Res. 1994;44:69–160.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Webster WS. Teratogen update: congenital rubella. Teratology. 1998;58(1):13–23.

    Article  CAS  PubMed  Google Scholar 

  46. Estofolete C, et al. Prevalence of measles antibodies in São José Do Rio Preto, São Paulo, Brazil: a serological survey model. Nat News, Nature Publishing Group, 20 Mar 2020, https://www.nature.com/articles/s41598-020-62151-3.

  47. Viral mumps: increasing occurrences in the vaccinated population. Oral Surg Oral Med Oral Pathol Oral Radiol, Mosby, 27 June 2019, https://www.sciencedirect.com/science/article/pii/S2212440319305619?casa_token=aHAU_UCRHxQAAAAA%3AcmJ97ppdDYLcH7IHf9kAzY-tISGHZOaeIaoYBLHcxVc6ldddKx2K4rTxf96mOSn3KUylcBE31-g#fig0001.

  48. Muliyil D, et al. Sero-prevalence of rubella among pregnant women in India, 2017. Vaccine, Elsevier, 15 Nov 2018, https://www.sciencedirect.com/science/article/pii/S0264410X18315263?casa_token=PB2bfHv7lHYAAAAA%3Af136rbYyUh1rbwXhr7h1JAd1d-iKTktD4hxBgKrTGhdHpaT3kJluzDOwS9W4txXDAt7glI6OsKQ.

  49. D’Souza RM, D’Souza R. Vitamin A for the treatment of children with measles—a systematic review. J Trop Pediatr. 2002;48(6):323–7.

    Article  PubMed  Google Scholar 

  50. Griffin DE, Oldstone MBA, editors. Measles: history and basic biology, vol. 329. Berlin: Springer Science & Business Media; 2008.

    Google Scholar 

  51. Nofal A, et al. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach. Int J Dermatol, U.S. National Library of Medicine. 2014. https://pubmed.ncbi.nlm.nih.gov/25070525/.

  52. About chickenpox. In: Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 28 Apr 2021, https://www.cdc.gov/chickenpox/about/index.html.

  53. Knobler SL, et al. The threat of pandemic influenza: are we ready? Workshop summary. Institute of Medicine (US) Forum on Microbial Threats, National Library of Medicine; 2005. https://www.ncbi.nlm.nih.gov/books/NBK22148/.

  54. LaFee S, Romero J. Herpes infected humans before they were human. UC Health – UC San Diego, 10 June 2014, https://health.ucsd.edu/news/releases/pages/2014-06-10-herpes-origins-in-chimpanzees.aspx#:~:text=This%20level%20of%20divergence%20indicated,humans%20roughly%20200%2C000%20years%20ago.

  55. A timeline of HIV and AIDS. HIV.gov, MHAF, 29 Apr 2022, https://www.hiv.gov/hiv-basics/overview/history/hiv-and-aids-timeline#:~:text=The%20HIV.gov%20Timeline%20reflects,risk%20for%2C%20HIV%20and%20AIDS.

  56. Chen Z, et al. Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans. PLoS Pathog. 2018;14(11). https://doi.org/10.1371/journal.ppat.1007352.

  57. Evans AS. The history of infectious mononucleosis. Am J Med Sci. 1974;267(3):189–95. https://doi.org/10.1097/00000441-197403000-00006.

    Article  CAS  PubMed  Google Scholar 

  58. History of measles. Centers for Disease Control and Prevention, CDC, 5 Nov 2020, https://www.cdc.gov/measles/about/history.html.

  59. Galetta KM, Gilden D. Zeroing in on zoster: a tale of many disorders produced by one virus. J Neurol Sci. 2015;358(1–2):38–45. https://doi.org/10.1016/j.jns.2015.10.004.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Oude Munnink BB, van der Hoek L. Viruses causing gastroenteritis: the known, the new and those beyond. Viruses. 2016;8(2):42. https://doi.org/10.3390/v8020042.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Littlejohn M, et al. Origins and evolution of hepatitis B virus and hepatitis D virus. Cold Spring Harb Perspect Med. 2016;6(1). https://doi.org/10.1101/cshperspect.a021360.

  62. Edwards H. The history of meningitis. In: Meningitis research foundation. Meningitis Research Foundation; 2020. https://www.meningitis.org/blogs/the-history-of-meningitis.

  63. Reimann HA. An acute infection of the respiratory tract with atypical pneumonia. J Am Med Assoc. 1938;111(26):2377. https://doi.org/10.1001/jama.1938.02790520033007.

    Article  Google Scholar 

  64. Pneumonia. In: Johns Hopkins Medicine. Johns Hopkins Medicine; 2021. https://www.hopkinsmedicine.org/health/conditions-and-diseases/pneumonia.

  65. Orenstein WA, Hinman A, Nkowane B, Olive JM, Reingold A. Measles and rubella global strategic plan 2012–2020 Midterm Review. Vaccine. Published 4 Jan 2018.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nova Southeastern University, University of South Florida, Tampa, FL, USA

    Sarika Chauhan, Surya Sankineni & Yashwant Pathak

  2. CapnoPharm GmbH, Tübingen, Germany

    Ranjita Shegokar

Authors
  1. Sarika Chauhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Surya Sankineni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ranjita Shegokar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yashwant Pathak
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. CapnoPharm GmbH, Tübingen, Germany

    Ranjita Shegokar

  2. Taneja College of Pharmacy, University of South Florida, Tampa, FL, USA

    Yashwant Pathak

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chauhan, S., Sankineni, S., Shegokar, R., Pathak, Y. (2023). Global Health and Viral Diseases: Past, Present, and Future. In: Shegokar, R., Pathak, Y. (eds) Viral Drug Delivery Systems. Springer, Cham. https://doi.org/10.1007/978-3-031-20537-8_1

Download citation

Publish with us

Policies and ethics

Search

Navigation